Nebenwirkungen · Cancidas (previously Caspofungin MSD)
CANCIDAS 50 mg powder for concentrate for solution for infusion CANCIDAS 70 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 6–7
HOS-109327 · Präparat HOS-093179
6 System Organ Common (≥1/100 to Uncommon (≥1/1,000 to <1/100) Not known Class <1/10) (cannot be estimated from available data) Blood and haemoglobin decreased, anaemia, thrombocytopaenia, lymphatic system haematocrit decreased, coagulopathy, leukopaenia, disorders white blood cell count eosinophil count increased, platelet decreased count decreased, platelet count increased, lymphocyte count decreased, white blood cell count increased, neutrophil count decreased Metabolism and hypokalaemia fluid overload, hypomagnesaemia, nutrition anorexia, electrolyte imbalance, disorders hyperglycaemia, hypocalcaemia, metabolic acidosis Psychiatric anxiety, disorientation, insomnia disorders Nervous system headache dizziness, dysgeusia, paraesthesia, disorders somnolence, tremor, hypoaesthesia Eye disorders ocular icterus, vision blurred, eyelid oedema, lacrimation increased Cardiac disorders palpitations, tachycardia, arrhythmia, atrial fibrillation, cardiac failure congestive Vascular phlebitis thrombophlebitis, flushing, hot disorders flush, hypertension, hypotension Respiratory, dyspnoea nasal congestion, pharyngolaryngeal thoracic and pain, tachypnoea, bronchospasm, mediastinal cough, dyspnoea paroxysmal disorders nocturnal, hypoxia, rales, wheezing Gastrointestinal nausea, diarrhoea, abdominal pain, abdominal pain disorders vomiting upper, dry mouth, dyspepsia, stomach discomfort, abdominal distension, ascites, constipation, dysphagia, flatulence Hepatobiliary elevated liver values cholestasis, hepatomegaly, disorders (alanine aminotransferase, hyperbilirubinaemia, jaundice, aspartate hepatic function abnormal, aminotransferase, blood hepatotoxicity, liver disorder, alkaline phosphatase, gamma-glutamyltransferase bilirubin conjugated, increased blood bilirubin) Skin and rash, pruritus, erythema, erythema multiforme, rash macular, Toxic subcutaneous hyperhidrosis rash maculo-papular, rash pruritic, epidermal tissue disorders urticaria, dermatitis allergic, pruritus necrolysis generalised, rash erythematous, rash and Stevens- generalised, rash morbilliform, skin Johnson lesion syndrome (see section 4.4) Musculoskeletal arthralgia back pain, pain in extremity, bone and connective pain, muscular weakness, myalgia tissue disorders Renal and renal failure, renal failure acute
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-08T16:40:00Z · SHA-256 6dd11a424b362e655ce61e4c49586bb6e658af1133d504982e2602258f5f83f7 · Passage 0541d48cf59f4d4a9954456b4057d65c67ffc142ac8c643ab01ae62a65c55e64 · Zeichen 2512–7152 im Abschnitt